Switch theme
Sign up to access all valuation multiples
Colgate-Palmolive (India) Ltd is a personal care and oral care company. The company operates under a single reportable segment, Personal Care (including Oral Care), which includes soaps, cosmetics, toilet preparations, and other products. The company manufactures oral-care products, such as toothpaste, toothbrushes, whitening products, and mouthwash solutions. Personal care products include body wash, hand soaps, skincare, and hair care. Geographically, the company generates a majority of its revenue within India and the rest from overseas markets.
1937
2.2K+
LTM Revenue $714M
LTM EBITDA $232M
$7.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Colgate-Palmolive India has a last 12-month revenue (LTM) of $714M and a last 12-month EBITDA of $232M.
In the most recent fiscal year, Colgate-Palmolive India achieved revenue of $703M and an EBITDA of $246M.
Colgate-Palmolive India expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Colgate-Palmolive India valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $714M | XXX | $703M | XXX | XXX | XXX |
| Gross Profit | $498M | XXX | $490M | XXX | XXX | XXX |
| Gross Margin | 70% | XXX | 70% | XXX | XXX | XXX |
| EBITDA | $232M | XXX | $246M | XXX | XXX | XXX |
| EBITDA Margin | 33% | XXX | 35% | XXX | XXX | XXX |
| EBIT | $214M | XXX | $210M | XXX | XXX | XXX |
| EBIT Margin | 30% | XXX | 30% | XXX | XXX | XXX |
| Net Profit | $168M | XXX | $168M | XXX | XXX | XXX |
| Net Margin | 24% | XXX | 24% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Colgate-Palmolive India's stock price is INR 2455 (or $29).
Colgate-Palmolive India has current market cap of INR 668B (or $7.8B), and EV of INR 657B (or $7.7B).
See Colgate-Palmolive India trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7.7B | $7.8B | XXX | XXX | XXX | XXX | $0.62 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Colgate-Palmolive India has market cap of $7.8B and EV of $7.7B.
Colgate-Palmolive India's trades at 11.1x EV/Revenue multiple, and 31.9x EV/EBITDA.
Equity research analysts estimate Colgate-Palmolive India's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Colgate-Palmolive India has a P/E ratio of 46.4x.
See valuation multiples for Colgate-Palmolive India and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $7.8B | XXX | $7.8B | XXX | XXX | XXX |
| EV (current) | $7.7B | XXX | $7.7B | XXX | XXX | XXX |
| EV/Revenue | 10.8x | XXX | 11.1x | XXX | XXX | XXX |
| EV/EBITDA | 33.2x | XXX | 31.9x | XXX | XXX | XXX |
| EV/EBIT | 35.9x | XXX | 37.0x | XXX | XXX | XXX |
| EV/Gross Profit | 15.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | 46.4x | XXX | 47.4x | XXX | XXX | XXX |
| EV/FCF | 47.1x | XXX | 51.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialColgate-Palmolive India's last 12 month revenue growth is 7%
Colgate-Palmolive India's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Colgate-Palmolive India's rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Colgate-Palmolive India's rule of X is 50% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Colgate-Palmolive India and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 33% | XXX | 35% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | 42% | XXX | 42% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 50% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 14% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 40% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Colgate-Palmolive India acquired XXX companies to date.
Last acquisition by Colgate-Palmolive India was XXXXXXXX, XXXXX XXXXX XXXXXX . Colgate-Palmolive India acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Colgate-Palmolive India founded? | Colgate-Palmolive India was founded in 1937. |
| Where is Colgate-Palmolive India headquartered? | Colgate-Palmolive India is headquartered in India. |
| How many employees does Colgate-Palmolive India have? | As of today, Colgate-Palmolive India has 2.2K+ employees. |
| Who is the CEO of Colgate-Palmolive India? | Colgate-Palmolive India's CEO is Ms. Prabha Narasimhan. |
| Is Colgate-Palmolive India publicy listed? | Yes, Colgate-Palmolive India is a public company listed on BOM. |
| What is the stock symbol of Colgate-Palmolive India? | Colgate-Palmolive India trades under 500830 ticker. |
| When did Colgate-Palmolive India go public? | Colgate-Palmolive India went public in 1991. |
| Who are competitors of Colgate-Palmolive India? | Similar companies to Colgate-Palmolive India include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Colgate-Palmolive India? | Colgate-Palmolive India's current market cap is $7.8B |
| What is the current revenue of Colgate-Palmolive India? | Colgate-Palmolive India's last 12 months revenue is $714M. |
| What is the current revenue growth of Colgate-Palmolive India? | Colgate-Palmolive India revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Colgate-Palmolive India? | Current revenue multiple of Colgate-Palmolive India is 10.8x. |
| Is Colgate-Palmolive India profitable? | Yes, Colgate-Palmolive India is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Colgate-Palmolive India? | Colgate-Palmolive India's last 12 months EBITDA is $232M. |
| What is Colgate-Palmolive India's EBITDA margin? | Colgate-Palmolive India's last 12 months EBITDA margin is 33%. |
| What is the current EV/EBITDA multiple of Colgate-Palmolive India? | Current EBITDA multiple of Colgate-Palmolive India is 33.2x. |
| What is the current FCF of Colgate-Palmolive India? | Colgate-Palmolive India's last 12 months FCF is $164M. |
| What is Colgate-Palmolive India's FCF margin? | Colgate-Palmolive India's last 12 months FCF margin is 23%. |
| What is the current EV/FCF multiple of Colgate-Palmolive India? | Current FCF multiple of Colgate-Palmolive India is 47.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
